Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 214

1.

Progressive Supranuclear Palsy: an Update.

Armstrong MJ.

Curr Neurol Neurosci Rep. 2018 Feb 17;18(3):12. doi: 10.1007/s11910-018-0819-5. Review.

PMID:
29455271
2.

Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxia: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Zesiewicz TA, Wilmot G, Kuo SH, Perlman S, Greenstein PE, Ying SH, Ashizawa T, Subramony SH, Schmahmann JD, Figueroa KP, Mizusawa H, Schöls L, Shaw JD, Dubinsky RM, Armstrong MJ, Gronseth GS, Sullivan KL.

Neurology. 2018 Feb 9. pii: 10.1212/WNL.0000000000005055. doi: 10.1212/WNL.0000000000005055. [Epub ahead of print]

PMID:
29440566
3.

Improving email strategies to target stress and productivity in clinical practice.

Armstrong MJ.

Neurol Clin Pract. 2017 Dec;7(6):512-517. doi: 10.1212/CPJ.0000000000000395.

4.

Lean NAFLD: A not so benign condition?

VanWagner LB, Armstrong MJ.

Hepatol Commun. 2018 Jan 16;2(1):5-8. doi: 10.1002/hep4.1143. eCollection 2018 Jan. No abstract available.

5.

Home-based exercise therapy in patients awaiting liver transplantation: protocol for an observational feasibility trial.

Williams FR, Vallance A, Faulkner T, Towey J, Kyte D, Durman S, Johnson J, Holt A, Perera MT, Ferguson J, Armstrong MJ.

BMJ Open. 2018 Jan 21;8(1):e019298. doi: 10.1136/bmjopen-2017-019298.

6.

Balancing exercise-induced weight loss with protein caloric requirement remains a challenge in overweight patients with cirrhosis.

Dhaliwal A, Towey J, Haydon G, Elsharkawy AM, Armstrong MJ.

Hepatology. 2018 Jan 22. doi: 10.1002/hep.29801. [Epub ahead of print] No abstract available.

PMID:
29357107
7.

Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, Gronseth GS, Marson D, Pringsheim T, Day GS, Sager M, Stevens J, Rae-Grant A.

Neurology. 2018 Jan 16;90(3):126-135. doi: 10.1212/WNL.0000000000004826. Epub 2017 Dec 27.

PMID:
29282327
8.

Editorial: monitoring blood pressure is key to the safe use of beta-blockers in patients with chronic liver failure.

Ferguson JW, Armstrong MJ.

Aliment Pharmacol Ther. 2018 Jan;47(2):300-301. doi: 10.1111/apt.14402. No abstract available.

PMID:
29265458
9.

Patient involvement in guidelines is poor five years after institute of medicine standards: review of guideline methodologies.

Armstrong MJ, Bloom JA.

Res Involv Engagem. 2017 Oct 2;3:19. doi: 10.1186/s40900-017-0070-2. eCollection 2017.

10.

Sex-specific cognitive-behavioural profiles emerging from individual variation in numerosity discrimination in Gambusia affinis.

Etheredge RI, Avenas C, Armstrong MJ, Cummings ME.

Anim Cogn. 2018 Jan;21(1):37-53. doi: 10.1007/s10071-017-1134-2. Epub 2017 Oct 11.

PMID:
29022119
11.

Shared decision-making in stroke: an evolving approach to improved patient care.

Armstrong MJ.

Stroke Vasc Neurol. 2017 Apr 16;2(2):84-87. doi: 10.1136/svn-2017-000081. eCollection 2017 Jun. Review.

12.

Title: 'Dysphagia: more than meets the eye?'

Armstrong MJ, Ahmed R, Boulton R.

Gastroenterology. 2017 Sep 22. pii: S0016-5085(17)36171-1. doi: 10.1053/j.gastro.2017.09.012. [Epub ahead of print] No abstract available.

PMID:
28947351
13.

Transplant-Free Survival Rates After Covered Transjugular Intrahepatic Portosystemic Shunt.

Schmidt-Martin D, Armstrong MJ, Rowe IA.

Gastroenterology. 2017 Sep;153(3):869-870. doi: 10.1053/j.gastro.2017.02.051. Epub 2017 Aug 3. No abstract available.

PMID:
28781224
14.

Fructose, uric acid, and zonal differences in NASH.

Mann JP, Armstrong MJ.

J Hepatol. 2017 Nov;67(5):1117-1118. doi: 10.1016/j.jhep.2017.06.029. Epub 2017 Jul 6. No abstract available.

PMID:
28690178
15.

Hospitalization and rehospitalization in Parkinson disease patients: Data from the National Parkinson Foundation Centers of Excellence.

Shahgholi L, De Jesus S, Wu SS, Pei Q, Hassan A, Armstrong MJ, Martinez-Ramirez D, Schmidt P, Okun MS.

PLoS One. 2017 Jul 6;12(7):e0180425. doi: 10.1371/journal.pone.0180425. eCollection 2017.

16.

Author response: Practice guideline summary: Treatment of restless legs syndrome in adults: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Allen RP, Armstrong MJ, Trenkwalder C, Zee PC, Winkelman JW.

Neurology. 2017 Jun 13;88(24):2337-2338. doi: 10.1212/WNL.0000000000004047. No abstract available.

PMID:
28607140
17.

Dementia with Lewy bodies advances: A new consensus report.

Barrett MJ, Armstrong MJ.

Neurology. 2017 Jul 4;89(1):18-19. doi: 10.1212/WNL.0000000000004071. Epub 2017 Jun 7. No abstract available.

PMID:
28592452
18.

Discordance Between Physician Assessment and Patient-Reported Depressive Symptoms in Parkinson Disease.

Lachner C, Armstrong MJ, Gruber-Baldini AL, Rezvani Z, Reich SG, Fishman PS, Salazar R, Shulman LM.

J Geriatr Psychiatry Neurol. 2017 Jul;30(4):191-195. doi: 10.1177/0891988717710335. Epub 2017 May 24.

PMID:
28535723
19.

Practice guideline summary: Reducing brain injury following cardiopulmonary resuscitation: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Geocadin RG, Wijdicks E, Armstrong MJ, Damian M, Mayer SA, Ornato JP, Rabinstein A, Suarez JI, Torbey MT, Dubinsky RM, Lazarou J.

Neurology. 2017 May 30;88(22):2141-2149. doi: 10.1212/WNL.0000000000003966. Epub 2017 May 10.

PMID:
28490655
20.

Caution in Using Non-Invasive Scoring Systems in NAFLD Beyond Highly Selected Study Populations.

Armstrong MJ, Schmidt-Martin D, Rowe IA, Newsome PN.

Am J Gastroenterol. 2017 Apr;112(4):653-654. doi: 10.1038/ajg.2017.28. No abstract available.

PMID:
28381853
21.

Recommendations for patient engagement in guideline development panels: A qualitative focus group study of guideline-naïve patients.

Armstrong MJ, Mullins CD, Gronseth GS, Gagliardi AR.

PLoS One. 2017 Mar 20;12(3):e0174329. doi: 10.1371/journal.pone.0174329. eCollection 2017.

22.

Use of theory to plan or evaluate guideline implementation among physicians: a scoping review.

Liang L, Bernhardsson S, Vernooij RW, Armstrong MJ, Bussières A, Brouwers MC, Gagliardi AR; Members of the Guidelines International Network Implementation Working Group.

Implement Sci. 2017 Feb 27;12(1):26. doi: 10.1186/s13012-017-0557-0. Review.

23.

Value Assessment at the Point of Care: Incorporating Patient Values throughout Care Delivery and a Draft Taxonomy of Patient Values.

Armstrong MJ, Mullins CD.

Value Health. 2017 Feb;20(2):292-295. doi: 10.1016/j.jval.2016.11.008.

24.

Naturalistic study of guideline implementation tool use via evaluation of website access and physician survey.

Armstrong MJ, Gronseth GS, Dubinsky R, Potrebic S, Penfold Murray R, Getchius TS, Rheaume C, Gagliardi AR.

BMC Med Inform Decis Mak. 2017 Jan 13;17(1):9. doi: 10.1186/s12911-016-0404-2.

25.

Response shift - The experience of disease progression in Parkinson disease.

Yang J, Hanna-Pladdy B, Gruber-Baldini AL, Barr E, von Coelln R, Armstrong MJ, Reich SG, Shulman LM.

Parkinsonism Relat Disord. 2017 Mar;36:52-56. doi: 10.1016/j.parkreldis.2016.12.027. Epub 2016 Dec 29.

PMID:
28082015
26.

How Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease?

Mann JP, Semple RK, Armstrong MJ.

Front Endocrinol (Lausanne). 2016 Nov 16;7:145. eCollection 2016. Review.

27.

Practice guideline summary: Treatment of restless legs syndrome in adults: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Winkelman JW, Armstrong MJ, Allen RP, Chaudhuri KR, Ondo W, Trenkwalder C, Zee PC, Gronseth GS, Gloss D, Zesiewicz T.

Neurology. 2016 Dec 13;87(24):2585-2593. Epub 2016 Nov 16.

28.

Standardized cell sources and recommendations for good cell culture practices in genotoxicity testing.

Lorge E, Moore MM, Clements J, O'Donovan M, Fellows MD, Honma M, Kohara A, Galloway S, Armstrong MJ, Thybaud V, Gollapudi B, Aardema MJ, Tanir JY.

Mutat Res. 2016 Oct;809:1-15. doi: 10.1016/j.mrgentox.2016.08.001. Epub 2016 Aug 3.

29.

Portopulmonary hypertension: Still an appropriate consideration for liver transplantation?

Verma S, Hand F, Armstrong MJ, de Vos M, Thorburn D, Pan T, Klinck J, Westbrook RH, Auzinger G, Bathgate A, Masson S, Holt A, Houlihan DD, Ferguson JW.

Liver Transpl. 2016 Dec;22(12):1637-1642. doi: 10.1002/lt.24625. Epub 2016 Nov 5.

30.

Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Jones DE, Sutliff MH, Halper J, Armstrong MJ, Brown TR, Haselkorn JK, Kraft GH, Narayanaswami P.

Neurology. 2016 Aug 9;87(6):646. doi: 10.1212/01.wnl.0000491123.28224.44. No abstract available.

PMID:
27502965
31.

Velocity Fluctuations in Kinesin-1 Gliding Motility Assays Originate in Motor Attachment Geometry Variations.

Palacci H, Idan O, Armstrong MJ, Agarwal A, Nitta T, Hess H.

Langmuir. 2016 Aug 9;32(31):7943-50. doi: 10.1021/acs.langmuir.6b02369. Epub 2016 Jul 26.

PMID:
27414063
32.

Liraglutide for patients with non-alcoholic steatohepatitis - Authors' reply.

Newsome PN, Armstrong MJ, Gaunt P.

Lancet. 2016 Jun 11;387(10036):2379. doi: 10.1016/S0140-6736(16)30672-9. No abstract available.

PMID:
27312304
33.

Identifying patients with nonalcoholic steatohepatitis that are nonresponders to therapy.

Armstrong MJ, Gaunt P, Newsome PN.

Hepatology. 2016 Dec;64(6):2265-2266. doi: 10.1002/hep.28672. Epub 2016 Jul 18. No abstract available.

PMID:
27287457
34.

Advanced non-alcoholic fatty liver disease and adipose tissue fibrosis in patients with Alström syndrome.

Gathercole LL, Hazlehurst JM, Armstrong MJ, Crowley R, Boocock S, O'Reilly MW, Round M, Brown R, Bolton S, Cramb R, Newsome PN, Semple RK, Paisey R, Tomlinson JW, Geberhiwot T.

Liver Int. 2016 Nov;36(11):1704-1712. doi: 10.1111/liv.13163. Epub 2016 Jun 10.

PMID:
27178444
35.

Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology.

Simpson DM, Hallett M, Ashman EJ, Comella CL, Green MW, Gronseth GS, Armstrong MJ, Gloss D, Potrebic S, Jankovic J, Karp BP, Naumann M, So YT, Yablon SA.

Neurology. 2016 May 10;86(19):1818-26. doi: 10.1212/WNL.0000000000002560. Epub 2016 Apr 18.

36.

Framework for enhancing clinical practice guidelines through continuous patient engagement.

Armstrong MJ, Rueda JD, Gronseth GS, Mullins CD.

Health Expect. 2017 Feb;20(1):3-10. doi: 10.1111/hex.12467. Epub 2016 Apr 26.

37.

Patient engagement and shared decision-making: What do they look like in neurology practice?

Armstrong MJ, Shulman LM, Vandigo J, Mullins CD.

Neurol Clin Pract. 2016 Apr;6(2):190-197.

38.

Exercise as Medicine: Key Concepts in Discussing Physical Activity with Patients who have Type 2 Diabetes.

Armstrong MJ, Sigal RJ.

Can J Diabetes. 2015 Dec;39 Suppl 5:S129-33. Review.

PMID:
26653253
39.

Portal inflammation is independently associated with fibrosis and metabolic syndrome in pediatric nonalcoholic fatty liver disease.

Mann JP, De Vito R, Mosca A, Alisi A, Armstrong MJ, Raponi M, Baumann U, Nobili V.

Hepatology. 2016 Mar;63(3):745-53. doi: 10.1002/hep.28374. Epub 2016 Jan 14.

PMID:
26638195
40.

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study.

Armstrong MJ, Gaunt P, Aithal GP, Barton D, Hull D, Parker R, Hazlehurst JM, Guo K; LEAN trial team, Abouda G, Aldersley MA, Stocken D, Gough SC, Tomlinson JW, Brown RM, Hübscher SG, Newsome PN.

Lancet. 2016 Feb 13;387(10019):679-90. doi: 10.1016/S0140-6736(15)00803-X. Epub 2015 Nov 20.

PMID:
26608256
41.

Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Haselkorn JK, Hughes C, Rae-Grant A, Henson LJ, Bever CT, Lo AC, Brown TR, Kraft GH, Getchius T, Gronseth G, Armstrong MJ, Narayanaswami P.

Neurology. 2015 Nov 24;85(21):1896-903. doi: 10.1212/WNL.0000000000002146. Review.

42.

Dual-5α-Reductase Inhibition Promotes Hepatic Lipid Accumulation in Man.

Hazlehurst JM, Oprescu AI, Nikolaou N, Di Guida R, Grinbergs AE, Davies NP, Flintham RB, Armstrong MJ, Taylor AE, Hughes BA, Yu J, Hodson L, Dunn WB, Tomlinson JW.

J Clin Endocrinol Metab. 2016 Jan;101(1):103-13. doi: 10.1210/jc.2015-2928. Epub 2015 Nov 17.

43.

Does impotence improve after parathyroidectomy in men with primary hyperparathyroidism?

Yoo JY, Yip L, Armstrong MJ, Carty SE, Kelley ML, Stang MT, McCoy KL.

Surgery. 2016 Jan;159(1):204-10. doi: 10.1016/j.surg.2015.06.055. Epub 2015 Oct 19.

PMID:
26492988
44.

Assessment of the MyWellness Key accelerometer in people with type 2 diabetes.

McGinley SK, Armstrong MJ, Khandwala F, Zanuso S, Sigal RJ.

Appl Physiol Nutr Metab. 2015 Nov;40(11):1193-8. doi: 10.1139/apnm-2015-0169. Epub 2015 Aug 10.

PMID:
26489052
45.

Effect of scavenger receptor class B type I antagonist ITX5061 in patients with hepatitis C virus infection undergoing liver transplantation.

Rowe IA, Tully DC, Armstrong MJ, Parker R, Guo K, Barton D, Morse GD, Venuto CS, Ogilvie CB, Hedegaard DL, McKelvy JF, Wong-Staal F, Allen TM, Balfe P, McKeating JA, Mutimer DJ.

Liver Transpl. 2016 Mar;22(3):287-97. doi: 10.1002/lt.24349.

46.

Behavioral Programs for Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-analysis.

Pillay J, Armstrong MJ, Butalia S, Donovan LE, Sigal RJ, Vandermeer B, Chordiya P, Dhakal S, Hartling L, Nuspl M, Featherstone R, Dryden DM.

Ann Intern Med. 2015 Dec 1;163(11):848-60. doi: 10.7326/M15-1400. Epub 2015 Sep 29. Review.

PMID:
26414227
47.

Behavioral Programs for Type 1 Diabetes Mellitus: A Systematic Review and Meta-analysis.

Pillay J, Armstrong MJ, Butalia S, Donovan LE, Sigal RJ, Chordiya P, Dhakal S, Vandermeer B, Hartling L, Nuspl M, Featherstone R, Dryden DM.

Ann Intern Med. 2015 Dec 1;163(11):836-47. doi: 10.7326/M15-1399. Epub 2015 Sep 29. Review.

PMID:
26414020
48.

Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis.

Armstrong MJ, Hull D, Guo K, Barton D, Hazlehurst JM, Gathercole LL, Nasiri M, Yu J, Gough SC, Newsome PN, Tomlinson JW.

J Hepatol. 2016 Feb;64(2):399-408. doi: 10.1016/j.jhep.2015.08.038. Epub 2015 Sep 21.

49.

Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients.

Yip L, Nikiforova MN, Yoo JY, McCoy KL, Stang MT, Armstrong MJ, Nicholson KJ, Ohori NP, Coyne C, Hodak SP, Ferris RL, LeBeau SO, Nikiforov YE, Carty SE.

Ann Surg. 2015 Sep;262(3):519-25; discussion 524-5. doi: 10.1097/SLA.0000000000001420.

50.

The clinical importance of parathyroid atypia: is long-term surveillance necessary?

McCoy KL, Seethala RR, Armstrong MJ, Nikiforova MN, Stang MT, Carty SE, Yip L.

Surgery. 2015 Oct;158(4):929-35; discussion 935-6. doi: 10.1016/j.surg.2015.06.022. Epub 2015 Jul 22.

PMID:
26210223

Supplemental Content

Loading ...
Support Center